OTTAWA, March 9 /CNW Telbec/ - Colorectal cancer is one of the most fatal
forms of cancer in Canada, killing approximately 163 Canadians each week.
"It is estimated that 20,000 men and women will be diagnosed with
colorectal cancer this year, and an estimated 8,500 will die from the disease"
states Dr. Philip Branton, Scientific Director of the CIHR Institute of Cancer
(ICR) based in Montreal. "We need more research to improve colorectal cancer
screening in Canada."
Several known risk factors are associated with colorectal cancer. These
include hereditary factors, age, diet and smoking. Knowing about these risk
factors and more screening can help to reduce the risk of colorectal cancer.
The CIHR-ICR has made the early detection of cancer one of its strategic
research priorities. Colorectal cancer screening falls within this priority.
Dr. Branton and several CIHR-funded researchers are available to comment
on different aspects related to colorectal cancer as Canada marks Colorectal
Cancer Awareness Month.
What are we doing to address this important health issue?
Dr. Branton, Scientific Director of the CIHR Institute of Cancer
An overview of colorectal screening in Canada
Dr. Heather Bryant, Chair of the Institute of Cancer Research Advisory
Board, Alberta Cancer Board (Calgary)
DNA testing for colorectal cancer?
Dr. Steven Gallinger, CIHR funded researcher & Senior Investigator of the
Samuel Lunenfeld Research Institute (Toronto)
Colorectal Cancer Screening in Ontario
Dr. Linda Rabaneck, CIHR funded researcher, Regional Vice President of
Cancer Care Ontario & Vice President of the Toronto Sunnybrook Regional Cancer
Examining the impact of genetic and non-genetic factors on Colorectal
Dr. John McLaughlin, CIHR funded researcher from the Samuel Lunenfeld
Research Institute and Cancer Care Ontario (Toronto)
Gender differences in colorectal cancer screening
Dr. Paul G. Ritvo, CIHR-funded researcher from University Health Network
Looking into Colonoscopy: is it worth the invasion?
Dr. Nancy Baxter, CIHR-funded researcher from the St. Michael's Hospital
Genetic breakthrough for colorectal cancer
Dr. Sean Cleary, CIHR-funded researcher from the University of Toronto,
Faculty of Medicine (Toronto)
Improving colorectal cancer care
Dr. Eva Grunfeld, CIHR-funded researcher from the University of
Dalhousie, Faculty of Medicine (Nova Scotia)
Canada's preferences for a colorectal cancer screening program
Dr. Robert Hilsden, CIHR-funded researcher from the University of
Calgary, Faculty of Medicine (Calgary)
Nutritional influence on colorectal cancer
Dr. Young-In Kim, CIHR-funded researcher from the University of Toronto,
Faculty of Medicine (Toronto)
Research training program to develop innovative and supportive cancer
How health information technology impacts people's adjustment to a new
Dr. Carmen Loiselle, CIHR-funded researcher from McGill University,
Faculty of Medicine (Montreal)
How Vitamin B deficiency increases the risk of colon cancer
Dr. Rima Rozen, CIHR-funded researcher from McGill University-Montreal
Children's Hospital. (Montreal)
How understanding chemotherapy resistance may increase prognosis and
survival of patients with of colorectal cancer
Dr. Isabella Tai, CIHR-funded researcher from the University of British
Columbia, Faculty of Medicine (Vancouver)
The Canadian Institutes of Health Research (CIHR) is the Government of
Canada's agency for health research. CIHR's mission is to create new
scientific knowledge and to catalyze its translation into improved health,
more effective health services and products, and a strengthened Canadian
health care system. Composed of 13 Institutes, CIHR provides leadership and
support to more than 10,000 health researchers and trainees across Canada.
Ce document est également disponible en français.
For further information:
For further information: For an interview, please contact: David
Coulombe, CIHR Media Specialist Office: (613) 941-4563, Mobile: (613)